Abstract
In 2014, treatment guidelines from the American Thyroid Association reflected the general consensus that levothyroxine (LT4), adjusted to maintain a normal thyrotropin (TSH) level, is the preferred method for treatment of hypothyroidism. Although this is generally applicable to children, there are subsets of children for whom the diagnosis and treatment of hypothyroidism are problematic. These include children with congenital hypothyroidism (CH), low birth weight (LBW) and very low birth weight (VLBW), Down syndrome (DS), subclinical hypothyroidism, and obesity. In this Review, we focus on the progress and remaining pitfalls in diagnosis and treatment of hypothyroidism in these and other groups.
Original language | English (US) |
---|---|
Pages (from-to) | 522-532 |
Number of pages | 11 |
Journal | Trends in Endocrinology and Metabolism |
Volume | 33 |
Issue number | 7 |
DOIs | |
State | Published - Jul 2022 |
Keywords
- acquired
- children
- congenital
- hypothyroidism
- levothyroxine
- therapy
- triiodothyronine
ASJC Scopus subject areas
- Endocrinology
- Endocrinology, Diabetes and Metabolism